About Alethio Therapeutics
Alethiomics is a biotech company harnessing the power of single-cell multi-omic technology to discover & develop treatment for blood cancer.
Sectors & Market Categories
Company Details
Corporate & Operational Profile
Primary Industry
Biotech & Healthcare
Funding Stage
Series-A
Global Headquarters
Abingdon-on-thames
Tracked Since
Nov 5, 2026
Web & Domain Identity
Official Website
alethiomics.com
Domain Registered Date
Undisclosed
Social & Network Presence
X / Twitter Profile
@companies
LinkedIn Corporate
Company Profile
Company Milestones & Timeline
- Capital Raise
Raised $90,000,000 · Series-A
Backed by RA Capital Management
Investors & Backers
RA Capital Management
Lead
Cancer Research Horizons
Oxford Science Enterprises
Sofinnova Partners
University of Oxford
Funding History
Series-A equity
· Nov 5, 2026
Round backers: RA Capital Management
$90,000,000 european-biotechnology.com
Founders & Leadership
Press Coverage & Sources
Recently Funded Biotech & Healthcare Startups
View allTesorai
tesorai.com
Seed Nov 2026
Commit Biologics
commitbio.com
Seed Aarhus · Nov 2026
Human Biome
human-biome.com
Series-A Warsaw · Nov 2026
MedInTech
medintech.co.kr
Series-B Seoul · Nov 2026
INFevo
infevo.ai
Seed Beijing · Nov 2026
Seawolf Therapeutics
seawolftx.com
Seed San Diego · Nov 2026